A detailed history of Joseph Group Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Joseph Group Capital Management holds 1,229 shares of PFE stock, worth $31,523. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,229
Previous 458 168.34%
Holding current value
$31,523
Previous $12,000 191.67%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$27.7 - $31.39 $21,356 - $24,201
771 Added 168.34%
1,229 $35,000
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $18,945 - $22,200
-750 Reduced 62.09%
458 $12,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $44,530 - $51,135
-1,720 Reduced 58.74%
1,208 $33,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $1.53 Million - $1.98 Million
-58,387 Reduced 95.22%
2,928 $84,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $475,188 - $555,448
14,808 Added 31.84%
61,315 $2.03 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $348,774 - $403,524
9,656 Added 26.2%
46,507 $1.71 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $225,547 - $293,629
5,726 Added 18.4%
36,851 $1.5 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $18,495 - $24,143
-443 Reduced 1.4%
31,125 $1.6 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $83,406 - $101,818
1,906 Added 6.43%
31,568 $1.38 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $18,472 - $21,902
397 Added 1.36%
29,662 $1.56 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $31,979 - $39,626
699 Added 2.45%
29,265 $1.52 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $1.15 Million - $1.71 Million
27,927 Added 4370.42%
28,566 $1.69 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $26,403 - $39,138
639 New
639 $1.69 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Joseph Group Capital Management Portfolio

Follow Joseph Group Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joseph Group Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Joseph Group Capital Management with notifications on news.